ESC 365 - Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with valsartan/amlodipine in prediabetic hypertensive patients

EAPC Premium Access

Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with valsartan/amlodipine in prediabetic hypertensive patients

Session: ePosters

Topic: Pharmacotherapy

Speaker: Doctor A. Liontos (Ioannina, GR)

Event: ESC Preventive Cardiology 2022

Congress Presentation

Add to my library

About the speaker

Doctor Angelos Liontos

University hospital of Ioannina, Ioannina (Greece)

1 follower

282 more presentations in this session

Small dense low-density lipoprotein profile in young acute coronary syndrome - a potential risk-stratification tool?

Monitoring pulmonary arterial pressures during cardiac rehabilitation using the CardioMEMS device

Speaker: Miss C. Chaudron (Montpellier, FR)

Comparison of inpatient and outpatient cardiac rehabilitation following myocardial infarction

Speaker: Professor P. Jankowski (Warsaw, PL)

Fas-ligand apoptotic pathway in anthracycline-induced heart failure

Coronary flow reserve in heart failure with preserved left ventricle ejection fraction

Access the full session

ePosters

Speakers: Doctor A. Liontos, Miss C. Chaudron, Professor P. Jankowski

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources